|
HS Code |
149949 |
| Product Name | Z-L-phenylglycine |
| Synonym | Z-Phg-OH |
| Chemical Formula | C15H13NO4 |
| Molecular Weight | 271.27 g/mol |
| Cas Number | 16652-46-9 |
| Appearance | White to off-white powder |
| Melting Point | 127-130°C |
| Optical Purity | L-enantiomer |
| Protection Group | Benzyloxycarbonyl (Z) |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Application | Peptide synthesis |
| Storage Conditions | Store at 2-8°C, keep container tightly closed |
As an accredited Z-L-phenylglycine(Z-Phg-OH) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a sealed, amber glass bottle containing 25g of Z-L-phenylglycine (Z-Phg-OH), labeled with chemical details and safety instructions. |
| Shipping | **Shipping Description for Z-L-phenylglycine (Z-Phg-OH):** Z-L-phenylglycine (Z-Phg-OH) is shipped in sealed, chemical-resistant containers to prevent contamination or degradation. The package is labeled according to relevant transport regulations and kept away from heat, moisture, and incompatible substances. Standard shipping methods for non-hazardous chemicals apply, with tracking and documentation included. |
| Storage | Z-L-phenylglycine (Z-Phg-OH) should be stored in a tightly sealed container, protected from light and moisture, at 2–8°C (refrigerator temperature). Keep the container in a well-ventilated, dry place away from incompatible substances such as strong oxidizers. Avoid prolonged exposure to air, as it may lead to degradation. Follow relevant safety and regulatory guidelines for chemical storage. |
Applications of Z-L-phenylglycine (Z-Phg-OH) in Industrial ManufacturingZ-L-phenylglycine (Z-Phg-OH) delivers targeted value in high-purity synthesis pathways across the pharmaceutical, peptide, and chemical research industries. As a professional manufacturer of advanced amino acid derivatives, we supply Z-Phg-OH tailored for precise applications in regulated environments requiring strict process control, consistent quality, and documented regulatory compliance. Below, we detail real-world downstream uses, technical guidance on integration, and associated regulatory considerations. 1. Peptide Synthesis for Research and Pharmaceutical API ManufacturingPeptide synthesis facilities rely on this protected L-phenylglycine derivative for stepwise solid-phase or solution-phase protocols, targeting selective coupling reactions where stereochemical integrity and protection group compatibility are critical. Z-Phg-OH enters the peptide chain assembly during elongation and segment condensation, especially beneficial when synthesizing non-proteinogenic peptide APIs or analogs. Application requires batch-level traceability, precise stoichiometry, and compatibility with orthogonal deprotection schemes favored in GMP manufacturing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Chiral Building Block for Custom API IntermediatesOrganic synthesis groups utilize the benzyl-protected L-phenylglycine as a chiral precursor to generate advanced intermediates for active pharmaceutical compounds. The material supports asymmetric transformations, including enantioselective alkylation and cyclization steps. During multi-step API development, this product ensures preservation of optical purity and structural integrity, aligning with strict impurity profiles demanded during validation and qualification of synthetic routes. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Protected Monomer for Specialty Oligomer SynthesisIndustrial peptide and oligomer manufacturers select Z-Phg-OH to introduce phenylglycine units with specific protecting patterns into tailored oligomer backbones. Applications span custom oligomer-based probes, enzyme inhibitors, or structural analogues where N-protection compatibility is essential for multistep assembly and post-synthetic modifications. Processing requires exacting moisture control, validated activation chemistry, and robust traceability for batch documentation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Functional Intermediate in Fine Chemical SynthesisFine chemical producers incorporate this protected amino acid derivative when creating specialty molecules used in catalyst development, ligand design, and research-scale synthesis of structurally unique compounds. Z-Phg-OH is effective for reactions requiring high selectivity such as enantioselective catalysis, and it undergoes strategic deprotection or further derivatization at later stages. Careful handling and documentation are required to meet traceability and downstream user specifications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Z-L-phenylglycine(Z-Phg-OH) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Unique raw materials change how chemists and manufacturers see each stage in the synthesis workflow. Z-L-Phenylglycine, a protected amino acid, stands out among specialty building blocks. In our facility, we turn to this particular derivative for its vital role in peptide synthesis and for its ability to provide selectivity, stability, and flexibility in multistep routes. Our process focuses on consistency—not only in purity but in how the product behaves in demanding conditions.
Chemists in both research and production have long seen the core value of Z-L-Phenylglycine: the Z-benzyl (carbobenzoxy, or Cbz) group protects the amine of the phenylglycine, preventing side reactions in peptide assembly. Through well-controlled manufacturing, we achieve lots with minimal racemization, which is important for optical purity. For every batch, strict in-process checks guide us in real time, making sure limits for metals and residual solvents stay within agreed parameters. While laboratories often talk about specs, we understand the balance between batch repeatability and adaptability for custom syntheses.
The main point with Z-L-Phg-OH lies in its consistent crystalline form, useful for lab-scale as well as scale-up runs. We continuously monitor moisture content and particle size distribution. Subtle changes make major differences in how this product integrates into automated peptide synthesizers or controlled, solid-phase synthesis setups. Free-flowing powder forms let users dose precisely, minimizing error and loss. Through rotary evaporation and specialized drying, we pull down water and residual organic vapors, keeping the product ready for extended storage without performance drop-off.
Color and odor, though rarely discussed in technical documents, act as on-the-spot quality indicators for experienced users. In our plant, skilled team members check every lot visually and by scent, preceding analytical confirmation. This habit grows out of years of experience—it’s not written in official pharmacopoeia, but it avoids costly surprises.
Analytical techniques back up these sensory tests. We run TLC plates in both non-polar and polar systems to confirm absence of unprotected glycine or side-products. HPLC and NMR analysis give a more detailed picture. Our confidence grows from parallel use of these techniques; we cross-check results, eliminate outliers, and routinely calibrate machines. Actual results, not mere claims, build trust.
Peptide synthesis serves as the direct destination for most of our output. Researchers often call for customized requests—from small mg pilot samples to multi-kilogram scale. Our production line scales flexibly based on need, guided each time by feedback from synthetic chemists. Certain steps, such as coupling or deprotection protocols, depend on subtle differences in protecting groups. The Cbz-protected phenylglycine allows for orthogonal removal compared to other protecting groups like Fmoc or Boc.
In addition to peptides, we’ve seen usage in pharmaceutical intermediates targeted at chiral drugs and bioactive compounds. Several generics manufacturers request Z-Phg-OH for active synthesis pathways where stereochemistry dictates pharmacological outcome. The consistent optical rotation of our product ensures batch-to-batch reliability. Users confirm our Z-Phg-OH in direct drug synthesis, feeding back results and adjustment suggestions, which we incorporate into our next production runs.
Specialty chemical companies also look at Z-L-Phg-OH for non-pharmaceutical applications. Fine chemicals, catalysts, and research laboratories draw from our stocks for their own diverse synthetic agendas. In these sectors, purity alone is not enough: a balanced physical property profile—such as bulk density, solubility in key solvents, and thermal stability—determines whether work proceeds smoothly.
On the surface, Z-L-Phg-OH aligns with other α-amino acid derivatives. In industrial practice, subtle differences change process performance. Some clients compare it against Fmoc- or Boc-protected phenylglycine. These alternatives have different stability and deprotection pathways. The Z- (Cbz-) protection is established and robust, especially for hydrogenolysis, avoided in Fmoc or acid-labile Boc settings. In our workflow, the Z group withstands both base- and acid-sensitive reactions, provided hydrogenation steps are planned with care.
Unprotected phenylglycine has limited direct usage in controlled synthesis because of its reactive amine. In peptide assembly, it leads to poor yields and potential side reactions. The Z-protected version blocks these routes, allowing controlled chain elongation. Processes sensitive to racemization benefit from the Z-Phg-OH as we track enantiopurity carefully throughout the workflow. The unprotected or free forms may seem cheaper but rarely deliver the same outcome when building complex peptides or chiral intermediates.
Our clients have discussed cost-performance with us, asking why not shift to protected analogues that claim easier handling. In hands-on trials, the handling characteristics of Z-Phg-OH—especially powder flow and low clumping—provided smoother reaction setups at both bench and pilot scales. Reactions benefitted from predictable dissolution profiles. Solvent compatibility became less of a bottleneck. Our product dissolves reliably in DMF, DCM, methanol, and select aqueous-organic blends, making it adaptable for routine and custom peptide libraries alike.
Manufacturing hundreds of lots each year, we see variation not captured in simple spec sheets. For large customers, we’ve supported projects that demand the same crystalline form, even after scale-up. Some peptide synthesis equipment operates best with powders in narrow size ranges. To meet these needs, we adjusted milling and sieving, using feedback from users to tweak granulation and surface area. The result was fewer clogs and less dust loss during transfer. Every iteration comes from the feedback loop between production, analytical teams, and end users.
Moisture control often affects stability and storage. We installed improved vacuum drying chambers, allowing for rapid throughput and less batch-to-batch drift. Product packed in lined, moisture-impermeable bags maintains quality even through extended shipping times, noted specifically by overseas clients.
Two years ago, a technical partner pointed out insoluble residues affecting a key step in a 40-step peptide pathway. By increasing our filtration accuracy and double-checking pre-shipment samples, we eliminated this problem. Practical improvements like these, drawn from user experience, drive our process upgrades.
We see purity as a baseline, not a differentiator, because every reputable supplier passes HPLC and NMR checks. What sets our Z-Phg-OH apart is not only purity but the details in batch reproducibility. While published specs might list “minimum 99% purity,” we analyze for common process impurities, monitor chiral purity to detect possible isomerization, and keep a log of physical parameters for every lot shipped.
Consistency in melting point and crystal habit support real-world formulation work. Chemists working on short timescales depend on raw materials that perform identically in every run, with negligible drift in yield or side product formation. That expectation drives our focus. Our in-house records and feedback archives let us trace every lot, confirming both inward and outward traceability as demanded by regulations but also as a matter of pride.
Every lot of Z-Phg-OH we ship leaves our plant packed for durability and ease of handling. Over the past decade, shipping damage and bulk caking dropped to near zero since we redesigned the lining bags and batch sealing system. Clients can stock product without rush. Long-term stability arises from both our post-synthesis conditioning and careful packing routines.
We pay attention to shipment size flexibility, knowing receiving departments in many labs handle both small vials and whole drums. Orders leave our warehouse with corresponding weights, split into appropriate units. This adaptability reduces wastage and keeps audits simple at the client’s premises. For GMP-compliant batches, certified documentation travels with the shipment, based on user feedback on what simplifies their compliance audits.
Chemical manufacturing means more than shipping finished goods. We stay involved with downstream applications, offering tailored support for custom syntheses, reaction troubleshooting, and application optimization. When a medicinal chemistry team required special isotope labeling for an SAR program, our team adjusted synthesis conditions, allowing us to provide stable isotope Z-Phg-OH on time. In another case, we extended shelf life testing and reported actual stability profiles to help a pharma customer align their regulatory submission with tested, real-world storage data.
The collective knowledge on our floor runs deep—process engineers, QC analysts, packing operators, and logistics specialists share notes after every large run. The result is more than technical conformity: it’s improved application success and fewer setbacks in clients’ own projects. Whether in academic screens or high-throughput contract manufacturing, our product’s track record reflects real partnership with users.
Raw materials can interrupt projects if not handled seriously. For example, low bulk density batches fall short during automated weighing. In response, we updated our drying and compaction system, eliminating the problem at the source. A recurring issue with trace metal contamination in one cycle led us to refine our raw material supplier check process. Now we accept fewer trace contaminants upstream, passing those gains onward in the finished product.
Another feedback loop surfaced when users experienced contamination during peptide purification stages. It traced back to minor impurities arising from aged reaction solvents in our own line. We invested in additional distillation and solvent monitoring, which cut these byproducts to trace levels or below. End users now benefit from cleaner starting material, which means smoother, higher-yielding final products.
Impossible to anticipate every problem, our philosophy remains grounded in openness—direct lines for feedback and real answers from our technicians, not just scripted response. This culture translates into faster resolution and less downtime for all parties.
A living knowledge base, not just SOPs, guides our Z-Phg-OH output. Each operator brings a practical perspective, identifying subtle changes in viscosity or filtration pressure that point to larger process shifts. By encouraging this knowledge sharing, we maintain tight process control while fostering creative solutions. Suppliers without this feedback system sometimes overlook minor but consequential process changes, only noticing issues after customer complaints. Our cycle closes the gap between production and application.
Analytical control remains robust but flexible. If a user’s special procedure demands tighter limits on any impurity, our team responds and adjusts protocols. This “open-door” approach reduces project risk and strengthens technical relationships across all application sectors.
Industry standards evolve alongside user expectations. Our facility holds third-party certifications that assure both documentation transparency and in-line control across the batch lifecycle. GMP-compliant lots receive enhanced monitoring and documentation. For non-GMP research-grade output, we maintain matching technical oversight, using the same LCMS, NMR, and FTIR instrumentation as on formal projects.
Quality control means more than paperwork. Actual walking audits and random batch pulls from stock prove that our Z-Phg-OH consistently matches published specs—often exceeding them. Audit trails, on-demand lot summaries, and detailed process records stand ready for client review, affirming our commitment to transparency and partnership.
The trend toward high-purity, protected amino acids will continue to shape our industry. Our investments match this progress—improved process lines, digital instrument management, and expanded analytical suites all benefit Z-Phg-OH clients. Input from R&D collaborations informs process tweaks that improve both product and user outcomes.
Growing interest from green chemistry pushes us to adapt solvents, catalysts, and energy practices—without compromising performance. Developments in solid-phase synthesis technology at client sites challenge us to develop ever more precise, low-dust, and easily handled products. We stay attentive to shifts in demand, regulatory outlook, and technical possibilities.
Practical engagement—not just a checklist—determines the reliability of specialty chemicals like Z-Phg-OH. Our log of user experiences, complaints, and success stories shapes not only our improvement projects but how we train new workers. For many projects, we anticipate technical requests and potential stumbling blocks, offering real support drawn straight from hands-on production and troubleshooting. Sometimes a shipment heads out with extra analytical data packs, not as a sales tactic but because one researcher’s query led to a new standard—the result of ongoing dialogue between maker and user.
We trust that by staying close to our products and our partners, every lot of Z-L-Phenylglycine we produce can lead to discoveries well beyond the walls of our plant. Our story is still being written—shaped by the people who use the results of our daily work.